SentenceSentimentTitleUrlDate
NEW YORK Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent as the drugmakers follow a similar move by rival Amgen Inc in hopes of increasing use of the drug PositiveNEW YORK Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent as the drugmakers follow a similar move by rival Amgen Inc in hopes of increasing use of the drug http://www.reuters.com/news/health/article/us-sanofi-fr-regeneron-cholesterol/sanofi-and-regeneron-cut-list-price-of-cholesterol-drug-by-60-percent-idUSKCN1Q019M2019-02-12
In March of last year Regeneron and Sanofi said that they would be willing to charge less for their drug if insurers agreed to reduce barriers for highrisk heart patients NegativeNEW YORK Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent as the drugmakers follow a similar move by rival Amgen Inc in hopes of increasing use of the drug http://www.reuters.com/news/health/article/us-sanofi-fr-regeneron-cholesterol/sanofi-and-regeneron-cut-list-price-of-cholesterol-drug-by-60-percent-idUSKCN1Q019M2019-02-12